派西拉生物科学

US · PCRX #3244 按市值排名

36.34 +0.01 +0.03%

实时 - 追踪5344个代码 - 心跳于357秒前 · 2026-10-16 19:30

✦ 量化股权信号计算方式说明

减持

机构持股总比例下降了0.4个百分点。

机构持股

机构持股比例: 114.14% -0.40pp
机构数量: 305
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Mutual Fund78.43%

Hedge Fund23.72%

Public Company8.64%

Individual/Insider2.21%

Government Pension Fund1.60%

Private Company0.69%

Bank/Investment Bank0.30%

Family Office/Trust0.27%

Insurance Company0.26%

主要股东截至 2026-06-30

BlackRock 16.82% · 6.71M 股

DOMA Perpetual Capital Management, LLC 6.97% · 2.78M 股

Vanguard Portfolio Management, LLC 6.04% · 2.41M 股

Dimensional Fund Advisors 5.28% · 2.10M 股

State Street Global Advisors 5.17% · 2.06M 股

Vanguard Capital Management, LLC 4.90% · 1.95M 股

D. E. Shaw & Co., L.P. 4.89% · 1.95M 股

Renaissance Technologies Corp. 4.35% · 1.73M 股

The Goldman Sachs Group, Inc. 2.95% · 1.17M 股

Geode Capital Management, LLC 2.91% · 1.16M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 23次买入 · 27次卖出

姓名	职务	持股比例
David Stack	Chairperson & CEO	0.60%
Shawn Cross	Chief Financial Officer	0.26%
Frank Lee	Chief Executive Officer	0.22%
Lauren Riker	Principal Accounting Officer & VP of Finance	0.16%
Jonathan Slonin	Chief Clinical Officer	0.16%
Charles Reinhart	Chief Financial Officer	0.10%
Kristen Dunker	--	0.06%
Mark Kronenfeld	Independent Director	0.05%
Laura Brege	Independent Director	0.04%
Mark Froimson	Independent Director	0.04%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-08-16	Jonathan Slonin	Chief Clinical Officer	Automatic Disposition	-3,040	$23.23
2026-06-11	Abraham Ceesay	Independent Director	Intent to Sell (Form 144)	-9,039	$23.27
2026-06-10	Lauren Riker	Principal Accounting Officer & VP of Finance	Automatic Disposition	-6,115	$23.50
2026-06-09	Laura Brege	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Laura Brege	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Thomas Wiggans	Independent Director	Other Derivative Acquisition	+32,675	$23.42
2026-06-09	Christopher Christie	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Christopher Christie	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Alethia Young	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Alethia Young	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Marcelo Bigal	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Marcelo Bigal	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Mark Froimson	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Mark Froimson	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Michael Yang	Independent Director	Other Acquisition	+6,405	--
2026-06-09	Michael Yang	Independent Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-09	Samit Hirawat	Director	Other Acquisition	+6,405	--
2026-06-09	Samit Hirawat	Director	Other Derivative Acquisition	+10,891	$23.42
2026-06-03	Kristen Dunker	--	Automatic Disposition	-10,259	$22.27
2026-06-02	Kristen Dunker	--	Sale to Issuer	-8,528	$22.32

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 19:30:04 · 仅供参考，不构成投资建议，也未考虑您的具体情况。